Healthcare provider profile · identity verified

Eric N Roberts, PAC

Physician Assistant · EVARTS, KY · NPI 1336576677

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	318	43
Lisinopril	Lisinopril	220	48
Pantoprazole Sodium	Pantoprazole Sodium	191	29
Atorvastatin Calcium	Atorvastatin Calcium	178	35
Amlodipine Besylate	Amlodipine Besylate	173	36
Omeprazole	Omeprazole	166	35
Metoprolol Tartrate	Metoprolol Tartrate	153	30
Fluticasone Propionate	Fluticasone Propionate	121	33
Tramadol Hcl	Tramadol Hcl	116	25
Furosemide	Furosemide	106	21
Metformin Hcl	Metformin Hcl	101	17
Levothyroxine Sodium	Levothyroxine Sodium	99	15
Losartan Potassium	Losartan Potassium	99	25
Pravastatin Sodium	Pravastatin Sodium	99	19
Hydrochlorothiazide	Hydrochlorothiazide	93	20
Prednisone	Prednisone	90	49
Eliquis	Apixaban	88	14
Albuterol Sulfate Hfa	Albuterol Sulfate	86	31
Sertraline Hcl	Sertraline Hcl	81	13
Tizanidine Hcl	Tizanidine Hcl	79	19
Rosuvastatin Calcium	Rosuvastatin Calcium	76	16
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	72	11
Potassium Chloride	Potassium Chloride	69	17
Tamsulosin Hcl	Tamsulosin Hcl	68	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	65	12
Trazodone Hcl	Trazodone Hcl	63	suppressed
Clonidine Hcl	Clonidine Hcl	62	17
Clonazepam	Clonazepam	61	11
Metoprolol Succinate	Metoprolol Succinate	60	suppressed
Ventolin Hfa	Albuterol Sulfate	58	21
Montelukast Sodium	Montelukast Sodium	56	14
Simvastatin	Simvastatin	52	13
Ondansetron Hcl	Ondansetron Hcl	49	19
Citalopram Hbr	Citalopram Hydrobromide	48	suppressed
Famotidine	Famotidine	48	suppressed
Azithromycin	Azithromycin	46	37
Farxiga	Dapagliflozin Propanediol	45	suppressed
Carvedilol	Carvedilol	44	suppressed
Duloxetine Hcl	Duloxetine Hcl	43	suppressed
Allopurinol	Allopurinol	41	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	11
Ibuprofen	Ibuprofen	40	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	39	suppressed
Meloxicam	Meloxicam	39	suppressed
Buspirone Hcl	Buspirone Hcl	38	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Nitroglycerin	Nitroglycerin	36	13
Donepezil Hcl	Donepezil Hcl	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Ozempic	Semaglutide	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	31	suppressed
Glipizide	Glipizide	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	21
Atenolol	Atenolol	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Fluconazole	Fluconazole	26	16
Pregabalin	Pregabalin	26	suppressed
Linzess	Linaclotide	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Cilostazol	Cilostazol	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	19	suppressed
Lidocaine	Lidocaine	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Primidone	Primidone	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Topiramate	Topiramate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Lubiprostone	Lubiprostone	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Nystatin	Nystatin	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Promethazine Hcl	Promethazine Hcl	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Felodipine Er	Felodipine	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Novolog	Insulin Aspart	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error